Stimulating the immune system to fight cancer.
This review describes the experience with the development of a novel form of immunotherapy that may represent the first practical and effective means of performing tumor-loaded dendritic cell immunotherapy.
According to national cancer institute statistic, Human cancer is comprised of more than 200 different diseases, Together they account for about one fifth of all deaths in the industrialized countries of the Western World.
One person out of three will be treated for a severe cancer in their lifetime. The incidence of most cancers increases with age; these figures are rising, as life expectancy continues to increase.
Facts: Surgery and radiotherapy are often successful in organ-confined cases, Chemotherapy is moderately effective for some
advanced cancers.
Cancer treatment needs to be carefully chosen to maximize the chance for a cure while retaining a quality of life, this fact is now widely accepted as a criterium for successful therapy.
What do we currently have ?
Effective cancer therapy requires an understanding of the principles of tumor biology, cellular kinetics, pharmacology and drug resistence,
Treatment of metastatic carcinomas remains the weakest point of current cancer therapy.
The combination of extracorporeal photopheresis with autologous dendritic cells vaccine, has substantial potential for the management of life-threatening or debilitating antigenic cancers and T-cell mediated disorders. These therapies are useful in the prevention of cancer recurrence after a complete remission, and are ideal in cases of therapy-resistant carcinomas. This therapy fights tumors with the person’s own immune system.
IIB (Instituto de Investigaciones Biomedicas) is a leader in the field of immunotherapy cancer treatments since 1999.
IIB is dedicated to providing care to our patients. Our main goal is to ease suffering.
We are committed to our patients. We treat people with dignity, respect, and hope. We are not promising a cure. What we can provide is a better quality and a longer life span. This therapy can be used alone or with chemotherapy and radiation.
The information on this site is highly technical. We are always available to answer any questions or assist you with your needs. Please feel free to contact us!
The Institute’s Center for Integrative Therapies was developed as a response to the great need for alternative Immunotherapies. This allows for whole person healing. It gives the patient a better quality of life and a prolonged survival rate. It is very useful for patients who have finished the conventional treatments but have the persistent risk of relapse. For example, there may be some residual disease left behind that has not yet been detected. (minima residual disease) ECP/DC therapy can help resolve this situation, giving the patient a better chance of prolonged remission. This treatment is also for all those patients who have been left with no hope because conventional treatments were unsuccessful. The ECP program is also for those seeking alternatives and other modalities to chemotherapy and radiation.
The Challenge: New Approaches to Cancer Therapy for the 21st century.
“A new scientific truth does not triumph by convincing its opponents, a new generation grows up that is familiar with it.” Max Karl Ernst Ludwig Planck. (1858-1947). German physicist who received the Nobel Prize for the creation of the quantum theory.
